Global Ganja Report

At the annual Vienna meeting of the Commission on Narcotic Drugs, the governing body of the UN Office on Drugs & Crime (UNODC) voted Dec. 2 to strike cannabis from Schedule IV of the 1961 Single Convention on Narcotic Drugs, the global treaty regulating drug control policy.

2019 saw advances for cannabis freedom on both the national and global stage—but also some near-misses, from New York state to Mexico, which have left activists frustrated if no less determined. As advocates prepare to carry the fight into 2020, here's a review of what was achieved—or almost achieved—over the past 12 months.

Paul Krassner, the legendary underground-press publisher, counterculture comedian, and the man credited with naming the Yippies, died July 21 at his home in Desert Hot Springs, Calif. He was 87 years old, and still active in radical press endeavors.

The East African nation of Uganda is preparing to become the continent's next big commercial cannabis producer. But after the Agriculture Ministry approved cultivation licenses, other cabinet ministers demanded that legality be clarified before planting commences. International investors are anxiously awaiting a resolution.

Albania is pledging another one of its endless and fruitless cannabis eradication campaigns, which never succeed in bumping the country from its spot as Europe's biggest illicit producer. The US is pressing the small Balkan nation for the campaign—and kicking in military aid.

Yet again, a scientific study linking cannabis use to psychiatric maladies gets widespread and sensationalistic media play. And once again, the assumptions behind the study are questionable, and the findings are further distorted by irresponsible reportage.

Does daily cannabis use, especially of high-potency "skunk" strains, lead to an increased risk of developing psychosis? Based on recent media coverage, you can be forgiven for thinking so. But you should really take a closer look before you believe the hype.

Counterintuitively, the world's top legal cannabis producer, the United Kingdom, is now importing its first shipments of medicinal cannabis prodccts, from Canada and the Netherlands. This is an advance for the UK medical marijuana program, but a proverbial case of "coals to Newcastle"—pointing to the paradoxes of cannabis globalization.

When the United Kingdom announced the historic step of rescheduling cannabis and allowing physicians to prescribe it two months ago, there was concern from patients and advocates as to whether actual herbaceous flower would be allowed, or only extracts. Now the first patient is approved to receive cannabis under the program, and it is indeed to be dried flower. The bad news: with the National Health Service barred by bureaucratic hurdles from providing it, patients are at the mercy of the market—and the price is prohibitive.